4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
Collaboration to leverage Q-Plasia OncoReader™ (QPOR™) on routine H&E slides to improve patient selection, accelerate clinical development, and deepen biological understanding of response Newton,…